The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity

Completed · Phase 1

Conditions studied: Breast Cancer

In brief

The purpose of this research study is to evaluate MR imaging in subjects receiving doxorubicin chemotherapy to see if MR can detect heart damage as well as or better than MUGA scans. This research study is expected to enroll approximately 10 subjects over 12 months at the University of Miami / Miller School of Medicine.

Key facts

Study ID

NCT00530101

Run by

University of Miami

People needed

3

Starts

2004-07-01

Expected to finish

2008-03-01

Last updated by the study team

2008-06-04

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Subject must have breast cancer and undergoing radiation treatment with a likelihood of developing cardiotoxicity.

You may not qualify if…

• Healthy subjects
• Males
• Subjects under the age of 18

Where it is running

• University of Miami Dept of Hematology/Oncology — Miami, Florida, United States
• University of Miami Dept of Radiology — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.